Income Statement
Balance Sheet
Cash Flow
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 |
|---|---|---|---|---|---|
| Total Revenue | 70,882 | 65,675 | 101,170 | 106,998 | 68,967 |
| Operating Revenue | 70,882 | 65,675 | 101,170 | 106,998 | 68,967 |
| Cost Of Revenue | 64,993 | 69,618 | 76,098 | 117,362 | 51,709 |
| Gross Profit | 5,889 | -3,943 | 25,072 | -10,364 | 17,258 |
| Selling General And Administration | 31,048 | 36,815 | 36,978 | 70,807 | 42,351 |
| General And Administrative Expense | 31,048 | 36,815 | 36,978 | 70,807 | 42,351 |
| Other Operating Expenses | 4,372 | 4,065 | 9,046 | 204,385 | 165.00 |
| Operating Expense | 73,223 | 75,104 | 88,022 | 324,637 | 54,992 |
| Operating Income | -67,334 | -79,047 | -62,950 | -335,001 | -37,734 |
| EBIT | -67,216 | -78,474 | -62,228 | -333,128 | -34,498 |
| Interest Expense | 1,730 | 1,704 | 1,679 | -892.00 | 3,913 |
| Interest Expense Non Operating | 1,730 | 1,704 | 1,679 | -892.00 | 3,913 |
| Net Interest Income | -1,730 | -1,704 | -1,679 | 892.00 | -3,913 |
| Other Income Expense | 118.00 | 573.00 | 722.00 | 1,873 | 3,236 |
| Other Non Operating Income Expenses | 118.00 | 573.00 | 722.00 | 1,873 | 3,236 |
| Pretax Income | -68,946 | -80,178 | -63,907 | -332,236 | -38,411 |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing And Discontinued Operation | -68,946 | -80,178 | -63,907 | -332,236 | -38,411 |
| Net Income From Continuing Operation Net Minority Interest | -68,946 | -80,178 | -63,907 | -332,236 | -38,411 |
| Net Income Including Noncontrolling Interests | -68,946 | -80,178 | -63,907 | -332,236 | -38,411 |
| Net Income Common Stockholders | -68,946 | -80,178 | -63,907 | -332,236 | -38,411 |
| Net Income | -68,946 | -80,178 | -63,907 | -332,236 | -38,411 |
| EBITDA | -29,413 | -44,250 | -20,230 | -283,683 | -22,022 |
| Normalized EBITDA | -29,413 | -44,250 | -20,230 | -283,683 | -22,022 |
| Reconciled Depreciation | 37,803 | 34,224 | 41,998 | 49,445 | 12,476 |
| Basic EPS | -0.01 | -0.01 | -0.01 | -- | -0.00 |
| Diluted EPS | -0.01 | -0.01 | -0.01 | -- | -0.00 |
| Basic Average Shares | 12.8M | 12.8M | 12.8M | -- | 12.8M |
| Diluted Average Shares | 12.8M | 12.8M | 12.8M | -- | 12.8M |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Income | -68,946 | -80,178 | -63,907 | -332,236 | -38,411 |
| Depreciation Amortization Depletion Income Statement | 37,803 | 34,224 | 41,998 | 49,445 | 12,476 |
| Diluted NI Availto Com Stockholders | -68,946 | -80,178 | -63,907 | -332,236 | -38,411 |
| Net Income Continuous Operations | -68,946 | -80,178 | -63,907 | -332,236 | -38,411 |
| Net Non Operating Interest Income Expense | -1,730 | -1,704 | -1,679 | 892.00 | -3,913 |
| Other Gand A | 24,748 | 30,515 | 30,678 | 62,076 | 36,351 |
| Reconciled Cost Of Revenue | 64,993 | 69,618 | 76,098 | 117,362 | 51,709 |
| Salaries And Wages | 6,300 | 6,300 | 6,300 | 8,731 | 6,000 |
| Total Expenses | 138,216 | 144,722 | 164,120 | 441,999 | 106,701 |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 |
|---|---|---|---|---|---|
| Cash And Cash Equivalents | 18,959 | 75,756 | 66,851 | 104,777 | 285,633 |
| Cash Cash Equivalents And Short Term Investments | 18,959 | 75,756 | 66,851 | 104,777 | 285,633 |
| Cash Financial | 18,959 | 75,756 | 66,851 | 104,777 | 285,633 |
| Accounts Receivable | 55,025 | 23,705 | 86,556 | 33,133 | 110,884 |
| Receivables | 55,025 | 23,705 | 86,556 | 33,133 | 110,884 |
| Prepaid Assets | 6,863 | 9,151 | 5,990 | 14,975 | 23,959 |
| Current Assets | 80,847 | 108,612 | 159,397 | 152,885 | 420,476 |
| Gross PPE | 1.1M | 1.1M | 1.1M | 1.1M | 773,242 |
| Accumulated Depreciation | -184,694 | -146,891 | -112,667 | -70,669 | -21,234 |
| Net PPE | 945,936 | 958,871 | 993,095 | 1.0M | 752,008 |
| Total Non Current Assets | 945,936 | 958,871 | 993,095 | 1.0M | 752,008 |
| Total Assets | 1.0M | 1.1M | 1.2M | 1.2M | 1.2M |
| Payables And Accrued Expenses | 113,313 | 86,798 | 93,333 | 66,591 | 255,795 |
| Current Liabilities | 113,313 | 86,798 | 93,333 | 66,591 | 260,992 |
| Other Non Current Liabilities | -- | -- | 200.00 | -- | -- |
| Total Non Current Liabilities Net Minority Interest | 466,906 | 465,176 | 463,672 | 461,793 | 465,203 |
| Total Liabilities Net Minority Interest | 580,219 | 551,974 | 557,005 | 528,384 | 726,195 |
| Common Stock | 1.2M | 1.2M | 1.2M | 1.2M | 646,714 |
| Capital Stock | 1.2M | 1.2M | 1.2M | 1.2M | 646,714 |
| Additional Paid In Capital | 172,761 | 172,761 | 172,761 | 172,761 | 173,230 |
| Retained Earnings | -918,911 | -849,966 | -769,988 | -705,881 | -373,645 |
| Common Stock Equity | 446,564 | 515,509 | 595,487 | 659,594 | 446,299 |
| Stockholders Equity | 446,564 | 515,509 | 595,487 | 659,594 | 446,299 |
| Total Equity Gross Minority Interest | 446,564 | 515,509 | 595,487 | 659,594 | 446,299 |
| Total Capitalization | 446,564 | 515,509 | 595,487 | 659,594 | 446,299 |
| Net Tangible Assets | 446,564 | 515,509 | 595,487 | 659,594 | 446,299 |
| Tangible Book Value | 446,564 | 515,509 | 595,487 | 659,594 | 446,299 |
| Working Capital | -32,466 | 21,814 | 66,064 | 86,294 | 159,484 |
| Invested Capital | 446,564 | 515,509 | 595,487 | 659,594 | 446,299 |
| Share Issued | 12.8M | 12.8M | 12.8M | 12.8M | 12.8M |
| Ordinary Shares Number | 12.8M | 12.8M | 12.8M | 12.8M | 12.8M |
| Current Provisions | -- | -- | -- | -- | 5,197 |
| Long Term Provisions | 466,906 | 465,176 | 463,472 | 461,793 | 465,203 |
| Properties | 1.1M | 1.1M | 1.1M | 1.1M | 773,242 |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 |
|---|---|---|---|---|---|
| Operating Cash Flow | -56,767 | 8,905 | -37,926 | -345,418 | 44,981 |
| Cash Flow From Continuing Operating Activities | -56,767 | 8,905 | -37,926 | -345,418 | 44,981 |
| Depreciation Amortization Depletion | 37,803 | 34,224 | 41,998 | 49,445 | 12,476 |
| Stock Based Compensation | 0.00 | 0.00 | -- | -469.00 | 0.00 |
| Change In Working Capital | -27,354 | 53,155 | -17,696 | -61,266 | 67,003 |
| Other Non Cash Items | 1,730 | 1,704 | 1,679 | -892.00 | 3,913 |
| Capital Expenditure | -24,869 | -- | -- | -- | -88,776 |
| Purchase Of PPE | -24,869 | -- | -- | 4,241 | -88,776 |
| Net PPE Purchase And Sale | -24,869 | -- | -- | 4,241 | -88,776 |
| Investing Cash Flow | 0.00 | 0.00 | -- | 164,562 | -88,776 |
| Cash Flow From Continuing Investing Activities | 0.00 | 0.00 | -- | 164,562 | -88,776 |
| Issuance Of Capital Stock | 0.00 | 0.00 | -- | 0.00 | 0.00 |
| Net Common Stock Issuance | 0.00 | 0.00 | -- | 0.00 | 0.00 |
| Financing Cash Flow | 0.00 | 0.00 | -- | 0.00 | 0.00 |
| Cash Flow From Continuing Financing Activities | 0.00 | 0.00 | -- | 0.00 | 0.00 |
| Changes In Cash | -56,797 | 8,905 | -37,926 | -180,856 | -43,795 |
| Beginning Cash Position | 75,756 | 66,851 | 104,777 | 285,633 | 329,428 |
| End Cash Position | 18,959 | 75,756 | 66,851 | 104,777 | 285,633 |
| Free Cash Flow | -81,636 | 8,905 | -37,926 | -341,177 | -43,795 |
| Common Stock Issuance | 0.00 | 0.00 | -- | 0.00 | 0.00 |
| Depletion | -- | 34,224 | -- | 49,445 | 12,476 |
| Net Income From Continuing Operations | -68,946 | -80,178 | -63,907 | -332,236 | -38,411 |
| Net Other Investing Changes | 24,869 | -- | -- | 160,321 | -- |